BI-78-D3 | Interleukin Related interleukin-related.com

Product Name :
BI-78-D3

Search keywords :
BI-78D3

drugId :
null

Target Vo:
c-Jun N-terminal kinase

Target Vo Short Name :
JNK

Moa_Name:
c-Jun N-terminal kinase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Burnham Institute for Medical Research

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Diabetes Mellitus, Type 2

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD45 Antibody (YA533)
Phospho-Hsp27 (Ser78) Antibody
Histone H1.2 Antibody: Histone H1.2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 21 kDa, targeting to Histone H1.2. It can be used for WB,ICC/IF,IHC-P,ChIP assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts